Investigators for both studies said ongoing analyses will help put the divergent management strategies into better context.

Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Our coverage of ACC 2025 in Chicago dominated our most-read stories, but other news on novel therapies made the list, too.

The novel aldosterone inhibitor works, but longer-term safety data are needed before the drug might be approved.